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Introductory paragraph (200 words) 28
Pathogens experience pressure in an infection to adapt, with selection favoring 29 mutants that persist. Pseudomonas aeruginosa commonly adapts by evolving 30 mutants with hyper-biofilm production that evade clearance. Despite our 31 understanding of the adaptive phenotypes, studying their emergence and dynamics 32 in an infection has proven challenging. Here we used a porcine full-thickness burn 33 wound model of chronic infection to study how mixed strains of P. aeruginosa 34 adaptively evolve. Wounds were infected with six P. aeruginosa strains, including the 35 model PA14 strain (PA14-1), and biopsies taken at 3, 14, and 28 days post-infection. 36
Rugose small-colony variants (RSCVs) were detected at 3-d and persisted, with the 37 majority evolved from PA14-1. Whole genome sequencing of PA14-1 RSCVs 38 revealed driver mutations exclusively in the wsp pathway. RSCVs also acquired 39 CRISPR-Cas adaptive immunity to prophages isolated from the P. aeruginosa wound 40 isolate (B23-2) present in the inoculum. The rapid rise of RSCVs to detectable 41 frequencies is evidence of positive selection of the Wsp chemosensory system and 42 suggests that RSCVs may arise earlier in an infection than originally appreciated, to 43 facilitate infection. Given the prevalence of RSCVs in chronic infections, we predict 44 that RSCVs may be a common, early adaptation during infections. of Pseudomonas aeruginosa to the cystic fibrosis (CF) lung 3 . CF patients exhibit 63 mucus accumulation, where P. aeruginosa biofilms commonly colonize the mucus 64 lining and establish persistent pulmonary infections [4] [5] [6] . Evolved phenotypic variants 65 of this organism are routinely isolated from CF patient sputum samples, and several 66 of these variants are often associated with worsening patient prognosis 7 . Of 67 particular interest are the rugose small-colony variants (RSCVs), which are isolated 68 from up to 50% of P. aeruginosa-positive CF sputum samples 8, 9 . When isolated, 69 their frequencies range drastically between 0.1 − 100% 9,10 . In contrast there is little-70 to-no reports of the frequency of P. aeruginosa adapted variants from other chronic 71 infections, such as chronic wound infections. 72
73
Common to RSCVs are mutations in pathways that lead to elevated cyclic 74 diguanylate monophosphate (c-di-GMP) 7 . C-di-GMP is a messenger molecule that 75 signals the transition from planktonic to biofilm lifestyle in many bacteria 11 . In P. 76 aeruginosa, increased c-di-GMP, among many responses, leads to overproduction of 77 exopolysaccharides, Psl and Pel, and matrix proteins 12, 13 . As a result, RSCVs have 78 hyper-biofilm phenotypes 13, 14 , increased tolerance to antimicrobials 10 , and enhanced 79 resistance to immunity 15, 16 . P. aeruginosa RSCVs also evolve from in vitro grown 80 biofilms 17, 18 , suggesting that there is strong selection for ecological diversification in 81 both in vivo and in vitro biofilms. 82 the wounds on 3-d (0.02 ± 0.12%) before peaking at 14-d, with a frequency of 139 approximately 2% (2.15 ± 5.25%) (Fig 2B) . On 28-d, the RSCV frequency decreased 140 to 0.19 ± 0.65% of the total bacterial burden (Fig 1B, 2B) . To determine if RSCVs 141 experienced selective pressure in the wound, we calculated the selection coefficient, 142 relative to the inoculum, at each timepoint across a range of possible starting 143 frequencies according to equation (1). RSCVs showed significant positive selection 144 across all time points with s >0.1 (Fig 2C) . Selection of RSCVs was similar across all 145 possible ranges on 3-d, while on 14-d and 28-d there was a gradual increase in 146 selection coefficients. Despite the RSCV frequency decreasing on 28-d (Fig 2B) , the 147 RSCVs still showed significant positive selection in order to rise from undetectable 148 frequencies to nearly 0.2% at 28-d (Fig 2C) . This indicates that across all time points, 149
RSCVs are adaptive. 150
151
RSCVs only evolved from the model strains PA14-1 and PAO1-B11 (Fig 2D) . These 152 also corresponded to the two RSCV phenotypes that were observed, with the pink 153
RSCVs evolving from PA14-1, and the orange from PAO1-B11 (Fig 2A) . RSCVs 154 derived from PA14-1 were isolated across all timepoints and PAO1-B11 evolved 155
RSCVs isolated from 14-d and 28-d. At the later two timepoints, PA14-1 RSCVs 156 remained the predominant sub-population (Fig 2D) . 157
158
Whole genome sequencing reveals that PA14-1 RSCVs contain driver 159 mutations exclusively within the wsp pathway 160
As PA14-1 RSCVs were the predominate evolved phenotype, we focused on this 161 sub-population for the remainder of the study. A description of the PAO1-B11 162 variants will be communicated elsewhere. Whole genome sequencing was performed 163 on 27 randomly selected PA14-1 RSCVs to identify the mutation(s) accounting for 164 the RSCV phenotype. 165
166
We identified putative driver mutations exclusively in the wsp cluster, specifically, 167 small deletions in wspA and wspF. (Table 1) . We identified an in-frame 42bp deletion 168 (Δ285 − 298aa) in wspA (wspA Δ285-298), and a frame-shift 5bp deletion (Δ461 − 169 465bp) in wspF (wspF V154fs) (Table 1) . RSCVs with the wspA mutation were 170 predominant across all timepoints, with wspF mutants only identified on 14-d. Using 171 RSCV-2 as a representative wspA mutant, the variant wspA was replaced on the 172 genome by a wildtype copy. This resulted in the RSCV colony phenotype reverting to 173 wildtype (Fig 3) , demonstrating that the wspA Δ285-298 mutation is responsible for 174 the RSCV phenotype. 175
176
Some of the RSCVs also possessed secondary mutations (Table 1) , demonstrating 177 further evolution in the wound. Two wspA RSCVs from 3-d (Table 1; RSCV-1 and  178 RSCV-4) acquired a 14,299bp deletion that removed the remaining psl operon. PA14 179 naturally lacks Psl, since pslA -pslD are absent 27 . In these two isolates the 180 remaining genes of the psl operon, pslE -pslO were deleted. Both of these PA14-1 181 RSCVs were isolated from the same wound, however from separate biopsied tissue, 182 suggesting that each deletion may have been a separate event. In the RSCV-1 183 background, complementation of wspA reverted the RSCV colony phenotype to 184 wildtype (Fig 3) (Fig 3),  195 indicating that the wspD mutations did not influence the RSCV phenotype. However, 196 this further points towards the strong selective pressure on the Wsp pathway in the 197 chronic infection. Table S2 ). These isolates had similar levels of biofilm 215 formation and metabolic kinetics compared to the ancestor strain (Supplemental 216
Results; Fig S7) , suggesting that the RSCVs were the major evolved sub-population 217 within the wounds. 218
219
WspA Δ285-298 mutation leads to auto-induction of the Wsp pathway 220
As the wspA Δ285-298 was the most common driver mutation, we investigated how it 221 may lead to elevated c-di-GMP production. We observed that flanking the junctions 222 of this deletion was a direct repeat at 837-854bp and 921-938bp (Fig S8; bold deletion of heptads N19 and N16 (Fig 4B) . 232
233
To observe the localization of the deletion in the protein structure and gain insight 234 into how the Δ285-298 mutation may alter the function and signaling of WspA, we 235 generated a homology model of PA14 WspA against the Thermotoga maritima MCP 236 (PDB 3JA6; 32 ) ( Fig 4C) . Our homology model is also supported by the WspA Phyre 237 secondary structure prediction 33 ( Fig S9) . Based on the model, the region of the 238 deletion is predicted to occur opposite the methylation site ( Fig 4C) . We predict that 239 the deletion could de-stabilize or alter the methylation site resulting in auto-induction 240 of WspA and sustained WspR activation. between the two isolates and aligned to the repetitive elements in the PA14 CRISPR 250 array (CRISPR2 34 ) (Fig 5A) . However, the first 32bp differed, indicative of CRISPR 251 spacer sequences (Fig 5A) , which are specific to infective mobile genetic elements 252 35 . A BLAST search of the inserted CRISPR spacer against the ancestor strains 253 identified that both insertions aligned to different contigs from strain B23-2 (See 254 Supplemental Results; Fig S10) . 255
256
We therefore predicted that RSCV-12 and -38 would be resistant to phages isolated 257 from B23-2 due to CRISPR-Cas-acquired adaptive immunity. To test this, we grew 258 B23-2 in mitomycin C and harvested the phage-enriched supernatant. P. aeruginosa 259 strains were incubated with the phage lysate and plaque assays were performed. 260 RSCV-12 and RSCV-38 displayed resistance to phage infection. RSCV-38 showed 261 resistance across all replicates (Fig 5B) . For RSCV-12, a single plaque was observed 262 in 1 replicate, however for the remaining 3 replicates no plaques were observed (Fig  263   5B ). This indicates that the acquired CRISPR spacers in RSCV-12 and RSCV-38 264 produced immunity to phages isolated from B23-2. Infection of RSCV-6 and RSCV-265 36 (CRISPR − ), which have the same driver mutation as RSCV-12 and RSCV-38 266 (CRISPR + ) respectively, revealed that RSCVs were not natively more resistant to 267 phage infection compared to the ancestor strain (Fig 5B) . The ancestor strain 268 susceptibility was also determined to assess the host range of the isolated phages. 269
As expected, B23-2 was resistant to phage infection, while the remaining strains 270 showed varying levels of phage sensitivity (CF18-1>MSH10-2, S54485-1>PA14-1, 271 PAO1-B11; Fig 5C) . 272 273 Discussion 274
Here we describe the rapid evolution of adaptive P. aeruginosa mutants with 275 conspicuous colony phenotypes arising in a clinically relevant model of chronic 276
infection. There is a consensus in the field that variants arise in an infection as a 277 consequence of adaptation over extended periods of time. However, we isolated 278
RSCVs from early stages of infection, suggesting that variants may evolve more 279 rapidly than originally appreciated. This suggests that RSCVs may be a common, 280 early adaptation during infections and that the selective pressures driving RSCV 281 evolution may persist across these infections. 282
283
Even though wounds were infected with six different P. aeruginosa strains, we only 284 isolated RSCVs evolved from PA14-1 and PAO1-B11 (Fig 2C) . We predict this is due 285 to PA14-1 and PAO1-B11 outcompeting the remaining four strains early in the 286 infection ( Fig 1C) . P. aeruginosa RSCVs were selected in the infection and in in vitro 287 conditions (Fig 2C, S5B) . The selection coefficients determined here were up to 5 288 times greater than those identified in the Lenski long-term evolution lines 36 , pointing 289 towards the strong positive selection experienced by RSCVs. Furthermore, 290
Burkholderia cenocepacia variants containing wsp mutations isolated from an in vitro 291 biofilm evolution assay similarly showed high selection coefficients 37 . This suggests 292 that wsp mutants experience significant positive selection both in vivo and in vitro 293 environments. Despite these strong selection coefficients, RSCVs remained at 294 relatively low frequencies in the infection (Fig 2B) . This suggests that RSCVs show 295 negative frequency dependence, that is, they exert a strong advantage at low 296 frequencies, but are disadvantageous at high frequencies. Negative frequency 297 dependent selection has been previously observed for evolved rugose variants of P. 298 and that wsp mutants may be more fit than other c-di-GMP-regulating pathways that 313 confer the RSCV phenotype. The wspA Δ285-298 was the most common driver 314 mutation and was isolated early in the infection (Table 1 ). There are two potential 315 explanations for the rapid rise of this single wspA mutant in the infection. The first is 316 that it may have been present in the initial inoculum at undetectable levels. The 317 second is that this region may be hyper-mutable owing to the direct repeat (Fig S8) . 318
We are currently unable to discern between these two scenarios; however, it is 319 significant that the population rapidly diversifies in the wound due to strong positive 320 selection of adaptive phenotypes provided by wsp mutations. 321
322
Supporting the second theory is the observation that this region in wspA also 323 appears to be under selection in driving RSCV evolution during in vitro grown biofilms 324 (Fig S11) . The P. aeruginosa PAO1 RSCV isolate MJK8, which evolved during 325 biofilm growth in a tube reactor 13 , has an in-frame 66bp deletion (Δ286 -307aa) in 326 the same region as wspA Δ285-298 12 . P. fluorescens Pfl01 when grown as a colony 327 biofilm evolved RSCVs with driver mutations identified in wspC, wspA and wspE 40 . 328
One of the wspA mutations was a in-frame 84bp deletion (Δ284 -311aa) again 329 occurring in the homologous region 40 . Finally, B. cenocepacia HI2424 RSCVs with 330 wspA and wspE mutations were isolated from a biofilm bead evolution experiment 37 . 331
While the majority of mutations identified were non-synonymous SNPs, one of the 332 wspA mutations was an in-frame 21bp deletion (Δ307-313aa) again in the 333 homologous region 37 (Fig S11) . We predict that these four deletions alter how WspA 334 is methylated/demethylated and ultimately lead to constitutive signaling and auto-335 induction of the Wsp pathway. 336
337
In addition to driver mutations, some PA14-1 RSCVs also gained secondary 338 mutations. Of particular interest was the Δ14,299bp, which deleted the remaining psl 339 operon (Table 1 ; RSCV-1). We predicted that this deletion might lead to increased 340 fitness of the RSCVs over the RSCV driver mutation alone. However, deletion of the 341 remaining psl operon did not provide additional fitness benefits under the simple 342 conditions tested. This suggests that in PA14 the remaining psl operon (pslE -pslO) 343 may play a role outside of Psl synthesis, which may have a fitness cost in the wound 344 environment. 345 346 Additional secondary mutations of interest were the 60bp insertions in the CRISPR-347
Cas array of RSCV-12 and RSCV-38 (Table 1, Fig 5A) , which encoded resistance to 348 phage(s) isolated from B23-2 (Fig 5C) . It has only recently been confirmed that the P. 349 aeruginosa type I-F CRISPR-Cas system provides adaptive immunity to phages with 350 a target protospacer 42 . This is dependent on the presence of the correct protospacer 351 adjacent motif (PAM) in the mobile genetic element 42 . In support of this, both 352 protospacers contain the type I-F CRSIPR-Cas specific GG PAM (Fig S10) . 353 Furthermore, B23-2 contig-107 contained two additional protospacers to which 354 CRISPR spacers in P. aeruginosa have been reported (Table S3 , Fig S10A) . Of 355 interest was the observation that PA14 already contains a CRISPR spacer identical 356 to a protospacer in contig-107 (Table S3 , Fig S10A) . This suggests that PA14 had 357 already been exposed to the prophage in B23-2. However, the ancestral PA14-1 was 358 still sensitive to infection (Fig 5B, C) , presumably due to the incorrect PAM (Fig  359   S10A ). This highlights the importance of insertion of the correct CRISPR spacer in 360 mediating phage immunity. This is only the second report of CRISPR-Cas acquired 361 immunity in P. aeruginosa strains 42 and to our knowledge the first report of CRISPR-362
Cas adaptive immunity acquired in an infection. 363
364
Our data indicate that P. aeruginosa experiences strong selective forces in chronic 365 infections, and in response rapidly evolve during the initial stages of infection. RSCVs 366 containing mutations in the wsp cluster were the main adapted sub-population 367 isolated from all wounds. This indicates that the Wsp system is the main pathway 368 under selection to evolve adapted variants. This is despite other pathways in c-di-369 GMP regulation being implicated in RSCV formation, both in vivo and in vitro [43] [44] [45] [46] [47] . 370 We predict that RSCVs may be an adaptation common to chronic infections and 371 developing therapies that target the RSCV sub-population or prevent their 372 emergence could be transferrable across these infections. 373 374
Materials and Methods 375

Bacterial strains, plasmids and media 376
Bacterial strains and plasmids used in this study are detailed in Table S1 . Gene 377 mutant constructs were made using Gibson Assembly (NEB) 48 . Primers used to 378 create the constructs are detailed in Table S4 . These were incorporated into the P. 379 aeruginosa genome using two-step allelic recombination as previously described 49 . 380 Porcine full-thickness chronic burn wound model was performed as previously 398 described 25 . Briefly, 2 pigs were subjected to thermal injury to achieve 6 full-399 thickness (third-degree) burns bilaterally and covered with impermeable wound 400 dressings. Burn wounds were infected 3 days post injury with equal amounts of 6 401 different P. aeruginosa strains to achieve a final 250µL inoculum at 10 8 bacteria (1.6 402 x10 7 each for a total of 1 x 10 8 ). The 250µL inoculum was spread over the wounds 403 and allowed to air dry before the wound dressing was re-applied. Wounds were 404 infected with PA14-1, PAO1-B11, B23-2, CF18-1 (GenBank ID; NZ_KI519281), 405 MSH10-2 (GenBank ID; NZ_KE138672) and S54485-1 (GenBank ID; NZ_KI519256). 406
Prior to infection, each strain had been tagged with a unique barcode at the Tn7 site 407 on the genome (see Supplementary Materials and Methods; Table 1) . 408 
Sequencing and analysis 431
To determine the frequency of each strain across the infection, genomic DNA was 432 isolated from porcine tissue and the barcodes were sequenced as follows. Tissue 433 was added to 2mL Goodman's buffer A (100 mM NaCl, 100 mM Tris-HCl pH 8, 10 434 mM EDTA pH 8, 3.33% SDS, 0.1% sodium deoxycholate) in a bead beater tube with 435 0.1mm glass beads and 2-3mm zirconia beads. The tissue was lysed by placing 436 tubes in a TissueLyser II (QIAGEN) for 30s at 50Hz. This was repeated 4 times, 437 placing tubes on ice for 30s in between each lysis round to prevent tubes from 438 overheating. Lysed tissue was incubated with 50µL proteinase K (20mg/mL) for 3h at 439 55°C. 2mL of phenol, chloroform, isomyl alcohol solution (25:24:1, pH 8) was added 440 and samples were centrifuged for 5min at room temperature. The aqueous phase 441 was removed and mixed with 1.5mL isopropanol. Sample was incubated for 30min at 442 -20°C before being centrifuged for 30min at 4°C. The pellet was washed in 1mL 75% 443
EtOH and again centrifuged. EtOH was removed and the DNA pellet air-dried and 444 resuspended in 500µL sterile water. Strain-specific barcodes were amplified and 445
given Illumina sequencing adapters using Tn7_F and Tn7_R primers indicated in 446 (https://github.com/glew8/Barcode_Sequencing). Briefly, FastQC 0.11.7 and MultiQC 453 v1.5 were used to confirm sufficient sequencing quality 52,53 . Cutadapt 1.13 was used 454 to select only those sequences with the insert sequence, isolate barcode sequence, 455 and parse reads containing each barcode 54 . Then egrep was used to count reads 456 with each barcode. As a final check, FastQC was used to identify overrepresented 457 sequences that don't match any of the queried barcodes. 458
459
To identify the ancestor strain that the isolated RSCVs evolved from, colony PCRs 460 were performed using primers specific to each ancestor strain. The forward primer 461 contained the unique barcode used to tag each ancestor strain at the Tn7 site. 462 Therefore, for each RSCV, 6 PCRs were performed. Primers are indicated in Table  463 S4. 464
465
To identify mutations, genomic DNA was isolated from colony variants using the 466 DNeasy Blood and Tissue Kit (Qiagen) according to the manufactures protocol. 467
Clonal DNA was sequenced on an Illumina NextSeq 500 using a modified protocol 468 for library prep using the Illumina Nextera kit 55 . 2x151bp sequencing reads for 469 selected isolates were trimmed and quality filtered using Trimmomatic v0.36 470 The number of resulting plaques was then counted and PFU/mL determined. 500
501
Statistical Analysis 502
Data are presented as mean ± SD. To determine if data conformed to a normal 503 distribution a Shapiro-Wilk test was performed. All of the data sets were normally 504 distributed except for the PFU/mL data ( Figure 5 ). For these data sets, means were 505 compared using the non-parametric t-test. All other comparisons were made using a 506 one-way ANOVA with a Tukey's post-hoc test and Student's t-test. Analyses were 507 performed using GraphPad Prism v.5 (Graphpad Software). 
